Clinical Trials

Acute Kidney Injury

Phase 2 Study of Reltecimod vs Placebo in Patients with Sepsis-associated Acute Kidney Injury

Hemodialysis

Comparison of Human Acellular Vessel (HAV) with Fistulas as Conduits for Hemodialysis

Kidney Cancer

A Study of XmAb20717 in Subjects with Selected Advanced Solid Tumors

A Study to Evaluate Ibrutinib Combination Therapy in Patients with Selected Gastrointestinal and Genitourinary Tumors

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients with Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

CANTATA: CB-839 with Cabozantinib vs Cabozantinib with Placebo in Patients with Metastatic Renal Cell Carcinoma

Nivolumab in Treating Patients with Localized Kidney Cancer Undergoing Nephrectomy

Prior Axitinib as a Determinant of Outcome of Renal Surgery

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

Study of Atezolizumab + Bevacizumab in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma

Study of HBI-8000 with Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer

Study of Optimized Management of Nivolumab Based on Response in Patients with Advanced RCC (OMNIVORE Study)

Study of TAK-228 In Patients with Previously Treated Metastatic Renal Cell Carcinoma

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475 in Combination with Epacadostat (INCB024360) in Subjects with Selected Cancers (INCB 24360-202/MK-3475-037/KEYNOTE-037/ECHO-202)

A Study of Atezolizumab as Adjuvant Therapy in Participants with Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy

BMS-936558 (MDX-1106) In Subjects with Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)

Cabozantinib-s-malate or Sunitinib Malate in Treating Patients with Previously Untreated Locally Advanced or Metastatic Kidney Cancer

FT500 as Monotherapy and in Combination with Immune Checkpoint Inhibitors in Subjects with Advanced Solid Tumors

Nivolumab Combined with Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)

Pazopanib Hydrochloride in Treating Patients with Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

S0931, Everolimus in Treating Patients with Kidney Cancer Who Have Undergone Surgery

Study of Cabiralizumab in Combination with Nivolumab in Patients with Selected Advanced Cancers

Study of Nivolumab (BMS-936558) vs Everolimus in Pre-Treated Advanced or Metastatic Clear-Cell Renal Cell Carcinoma (CheckMate 025)

Kidney Disease

Decision Aid for Renal Therapy

Gout: Allopurinol vs Febuxostat

Phosphate Microvascular Study

The COMBINE Study: The CKD Optimal Management with Binders and Nicotinamide

Kidney Transplant

Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Receipients

HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients

Nephrolithiasis

​Endourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2

A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Kidney Stone Surgery (Percutaneous Nephrolithotomy [PCNL])

Nephropathic Cystinosis

Cure Cystinosis International Registry

Renal Pelvis Carcinoma

Rucaparib in Patients with Locally Advanced or Metastatic Urothelial Carcinoma